The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 29, 2014

Filed:

Jun. 23, 2008
Applicants:

Rajeev Aurora, Wildwood, MO (US);

Maureen J. Donlin, Kirkwood, MO (US);

John E. Tavis, Kirkwood, MO (US);

Inventors:

Rajeev Aurora, Wildwood, MO (US);

Maureen J. Donlin, Kirkwood, MO (US);

John E. Tavis, Kirkwood, MO (US);

Assignee:

Saint Louis University, St. Louis, MO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G06F 19/22 (2011.01); G06F 19/24 (2011.01); G06F 19/00 (2011.01); A61K 38/21 (2006.01); A61K 31/7056 (2006.01);
U.S. Cl.
CPC ...
G06F 19/22 (2013.01); G06F 19/24 (2013.01); G06F 19/3443 (2013.01); G06F 19/3456 (2013.01); A61K 38/212 (2013.01); A61K 31/7056 (2013.01);
Abstract

Methods of identifying targets for designing a therapeutic agent are disclosed. These methods comprise: determining an amino acid sequence of one or more polypeptides of each isolate of a plurality of isolates of a biological system; identifying covariance pairs of amino acid residues; establishing a network comprising the covariance pairs; and identifying one or more hub residue positions, wherein a hub residue position comprises a target for designing a therapeutic agent if the hub residue position has a rank order in the 40percentile or greater. In other aspects, methods are disclosed for selecting a therapy for an infectious disorder. In various configurations, these methods comprise: determining amino acids occupying a plurality of diagnostic amino acid residue positions comprised by one or more polypeptides encoded by an infectious agent infecting a subject; and assigning the infectious agent infecting the subject to one covariance network selected from a plurality of covariance networks, wherein each network comprises a unique rank order of hubs with respect to the other networks, and whereby the therapy is selected on the basis of the covariance network assignment.


Find Patent Forward Citations

Loading…